ES2196181T3 - Derivados de purina y proceso para su preparacion. - Google Patents
Derivados de purina y proceso para su preparacion.Info
- Publication number
- ES2196181T3 ES2196181T3 ES96934774T ES96934774T ES2196181T3 ES 2196181 T3 ES2196181 T3 ES 2196181T3 ES 96934774 T ES96934774 T ES 96934774T ES 96934774 T ES96934774 T ES 96934774T ES 2196181 T3 ES2196181 T3 ES 2196181T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- purine derivatives
- diseases
- quinasa
- lina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBEN DERIVADOS DE LA 2 - AMINO - 6 - ANILINO - PURINA DE FORMULA (1) EN LA CUAL LOS SIMBOLOS SE DEFINEN EN LA REIVINDICACION 1. ESTOS COMPUESTOS INHIBEN LA P34 CDC2 /CIC LINA B CDC13 - QUINASA Y SE PUEDEN UTILIZAR PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS, COMO POR EJEMPLO ENFERMEDADES TUMORALES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH309495 | 1995-11-01 | ||
CH221396 | 1996-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2196181T3 true ES2196181T3 (es) | 2003-12-16 |
Family
ID=25689809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96934774T Expired - Lifetime ES2196181T3 (es) | 1995-11-01 | 1996-10-22 | Derivados de purina y proceso para su preparacion. |
Country Status (14)
Country | Link |
---|---|
US (1) | US7091346B1 (es) |
EP (1) | EP0874846B1 (es) |
JP (2) | JP4004066B2 (es) |
CN (1) | CN1066147C (es) |
AR (1) | AR004134A1 (es) |
AT (1) | ATE236161T1 (es) |
AU (1) | AU7296896A (es) |
BR (1) | BR9611157A (es) |
CA (1) | CA2234609C (es) |
DE (1) | DE69627195T2 (es) |
ES (1) | ES2196181T3 (es) |
HK (1) | HK1016580A1 (es) |
PT (1) | PT874846E (es) |
WO (1) | WO1997016452A1 (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6794390B2 (en) * | 1996-08-02 | 2004-09-21 | Cv Therapeutics, Inc. | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
WO1998016528A1 (en) * | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
EP1003746A1 (en) | 1997-08-07 | 2000-05-31 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
US6573044B1 (en) | 1997-08-07 | 2003-06-03 | The Regents Of The University Of California | Methods of using chemical libraries to search for new kinase inhibitors |
HUP0004512A3 (en) | 1997-10-27 | 2003-01-28 | Agouron Pharmaceuticals Inc La | 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
WO1999031072A1 (en) * | 1997-12-18 | 1999-06-24 | E.I. Du Pont De Nemours And Company | Cyclohexylamine arthropodicides and fungicides |
US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
ES2219038T3 (es) * | 1998-02-26 | 2004-11-16 | Aventis Pharmaceuticals Inc. | 2-(trans-(4-aminociclohexil)amino)purinas 6,9-disustituidas. |
US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
US6642231B2 (en) * | 1998-02-26 | 2003-11-04 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
UA66840C2 (uk) * | 1998-02-26 | 2004-06-15 | Авентіс Фармасьютікалз Інк. | 6,9-дизаміщені 2-[транс-(4-аміноциклогексил)аміно]пурини, фармацевтична композиція та способи лікування проліферативного розладу, попередження апоптозу нервових клітин, захисту нервових клітин від руйнування |
CZ27399A3 (cs) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
DE60118521T2 (de) * | 2000-01-07 | 2006-10-12 | Universitaire Instelling Antwerpen | Purin derivate, ihre herstellung und verwendung |
WO2001082967A1 (en) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | MEDICINAL COMPOSITIONS FOR SUPPRESSING β-AMYLOID PRODUCTION |
US6861524B2 (en) | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
ATE301123T1 (de) | 2001-06-27 | 2005-08-15 | Cyclacel Ltd | 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten |
CA2810339A1 (en) * | 2001-08-10 | 2003-02-20 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
GB0219052D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
US7151104B2 (en) * | 2002-09-19 | 2006-12-19 | Schering Corporation | Pyrazolopyridines as cyclin dependent kinase inhibitors |
WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
CA2520465A1 (en) | 2003-03-28 | 2004-10-14 | Scios Inc. | Bi-cyclic pyrimidine inhibitors of tgf.beta. |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
US7601713B2 (en) | 2005-12-15 | 2009-10-13 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
MY148427A (en) | 2006-12-08 | 2013-04-30 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
AU2007333394C1 (en) * | 2006-12-08 | 2011-08-18 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
MX2009010122A (es) | 2007-03-28 | 2009-10-19 | Neurosearch As | Derivados de purinilo y su uso como moduladores del canal de potasio. |
US20100105705A1 (en) * | 2007-03-28 | 2010-04-29 | Neurosearch A/S | Purinyl derivatives and their use as potassium channel modulators |
CZ302225B6 (cs) * | 2007-07-04 | 2010-12-29 | Univerzita Palackého v Olomouci | Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny |
CA2720946C (en) * | 2008-04-07 | 2013-05-28 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
EP2344501A1 (en) * | 2008-09-26 | 2011-07-20 | NeuroSearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
WO2010034707A1 (en) | 2008-09-26 | 2010-04-01 | Neurosearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
BR112013023050A8 (pt) | 2011-03-09 | 2018-09-25 | G Pestell Richard | antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um composto candidato, para produzir in vitro células epiteliais primárias, para diagnosticar câncer de próstata, para selecionar um tratamento para um indivíduo tendo um câncer/tumor de próstata, linhagem de célula, e, modelo animal |
WO2013074986A1 (en) | 2011-11-17 | 2013-05-23 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
CA2873743C (en) | 2012-05-14 | 2022-12-06 | Prostagene, Llc | Using modulators of ccr5 for treating cancer |
CA2876780A1 (en) | 2012-06-26 | 2014-01-03 | Saniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
CN105283206B (zh) * | 2013-03-27 | 2019-11-08 | 财团法人峨山社会福祉财团 | 包含p34的表达抑制剂或活性抑制剂作为有效成分的用于治疗或转移抑制癌的组合物 |
AU2014337044A1 (en) | 2013-10-18 | 2016-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
CN108064274A (zh) | 2014-07-30 | 2018-05-22 | 耶达研究及发展有限公司 | 用于培养多能干细胞的培养基 |
CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
EP3273966B1 (en) * | 2015-03-27 | 2023-05-03 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
WO2017044858A2 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
CN114149432B (zh) * | 2016-09-30 | 2024-07-05 | 斯坦福国际研究院 | 用于癌症治疗的双重clk/cdk1抑制剂 |
WO2020152686A1 (en) | 2019-01-23 | 2020-07-30 | Yeda Research And Development Co. Ltd. | Culture media for pluripotent stem cells |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3529497A1 (de) * | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
AU626983B2 (en) * | 1989-01-31 | 1992-08-13 | Whitby Research, Inc. | N6-substituted 9-methyladenines |
DK0625158T3 (da) * | 1992-01-06 | 1999-10-11 | Wellcome Found | Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken |
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
US5866702A (en) | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US5753635A (en) | 1996-08-16 | 1998-05-19 | Berlex Laboratories, Inc. | Purine derivatives and their use as anti-coagulants |
WO1998016528A1 (en) | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
-
1996
- 1996-10-22 CN CN96198457.0A patent/CN1066147C/zh not_active Expired - Fee Related
- 1996-10-22 PT PT96934774T patent/PT874846E/pt unknown
- 1996-10-22 JP JP50604797A patent/JP4004066B2/ja not_active Expired - Fee Related
- 1996-10-22 CA CA002234609A patent/CA2234609C/en not_active Expired - Fee Related
- 1996-10-22 AU AU72968/96A patent/AU7296896A/en not_active Abandoned
- 1996-10-22 EP EP96934774A patent/EP0874846B1/en not_active Expired - Lifetime
- 1996-10-22 DE DE69627195T patent/DE69627195T2/de not_active Expired - Lifetime
- 1996-10-22 US US09/051,827 patent/US7091346B1/en not_active Expired - Fee Related
- 1996-10-22 AT AT96934774T patent/ATE236161T1/de not_active IP Right Cessation
- 1996-10-22 WO PCT/EP1996/004573 patent/WO1997016452A1/en active IP Right Grant
- 1996-10-22 ES ES96934774T patent/ES2196181T3/es not_active Expired - Lifetime
- 1996-10-22 BR BR9611157A patent/BR9611157A/pt not_active Application Discontinuation
- 1996-10-30 AR ARP960104961A patent/AR004134A1/es unknown
-
1999
- 1999-04-08 HK HK99101415A patent/HK1016580A1/xx not_active IP Right Cessation
-
2007
- 2007-06-05 JP JP2007148965A patent/JP2007231023A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE236161T1 (de) | 2003-04-15 |
HK1016580A1 (en) | 1999-11-05 |
JPH11514336A (ja) | 1999-12-07 |
BR9611157A (pt) | 1999-03-30 |
CN1202896A (zh) | 1998-12-23 |
CA2234609A1 (en) | 1997-05-09 |
JP4004066B2 (ja) | 2007-11-07 |
EP0874846B1 (en) | 2003-04-02 |
WO1997016452A1 (en) | 1997-05-09 |
AR004134A1 (es) | 1998-09-30 |
CA2234609C (en) | 2006-11-28 |
DE69627195D1 (de) | 2003-05-08 |
US7091346B1 (en) | 2006-08-15 |
PT874846E (pt) | 2003-08-29 |
EP0874846A1 (en) | 1998-11-04 |
CN1066147C (zh) | 2001-05-23 |
AU7296896A (en) | 1997-05-22 |
JP2007231023A (ja) | 2007-09-13 |
DE69627195T2 (de) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196181T3 (es) | Derivados de purina y proceso para su preparacion. | |
DE69912606D1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate | |
YU50800A (sh) | Derivati 2-(purin-9-il)-tetrahidrofuran-3,4-diola | |
AP2000002016A0 (en) | 2-(Purin-9-yl) Tetrahydrofuran-3,4-diol derivatives. | |
YU44900A (sh) | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola | |
ES2122076T3 (es) | Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos. | |
AP2000002013A0 (en) | 2-(Purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives. | |
ES2184705T3 (es) | 4-oxo-4,7-dihidro-tieno(2,3-b)piridina-5-carboxamidas como agentes antivirales. | |
YU21401A (sh) | Tetrahidropiridoetri | |
AU551324B2 (en) | Phosphoramidite derivatives of nucleotides and their use in preparation of oligonucleotides | |
GB9903762D0 (en) | Organic compounds | |
TR199800012T1 (xx) | Piroloprimidinler ve preparasyon i�in tatbikler. | |
CY2538B1 (en) | Tetrahydropyrido compounds | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
AU1044500A (en) | Imidazonaphthyridines | |
MXPA01008346A (es) | Compuestos quimicos. | |
EA200500934A1 (ru) | Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний | |
ES2166900T3 (es) | Derivados de ara-c. | |
ATE251162T1 (de) | Triazolo(4,5-d)pyrimidin-verbindungen | |
ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico | |
ES2144857T3 (es) | Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. | |
ITMI911877A1 (it) | Enzimi fibrinolitici ammidati e loro precursori, e processi per la loro preparazione. | |
TW377353B (en) | Purine derivatives and process for their preparation | |
MX9306395A (es) | Intermediarios novedosos para la preparacion de derivados 5,6-dihidropirrolo /2,3-d/-pirimidina y procesamiento para su obtencion. |